Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy

Cancer

Volumn 119, Issue 8, 2013, Pages 1528-1536

  Sinicrope, Frank A ^a   Foster, Nathan R ^a   Yothers, Greg ^b   Benson, Al ^c   Seitz, Jean Francois ^d   Labianca, Roberto ^e   Goldberg, Richard M ^f   Degramont, Aimery ^g   O'Connell, Michael J ^b   Sargent, Daniel J ^a  

^a North Central Cancer Treatment Group Rochester   (United States)

^b National Adjuvant Breast and Bowel Project   (United States)

^c Eastern Cooperative Oncology Group   (United States)

^d AIX MARSEILLE UNIVERSITY   (France)

^e Riuniti Hospital   (Italy)

^f Cancer and Leukemia Group B   (United States)

^g Multidisciplinary Cooperative Oncology Group   (France)

Author keywords

adjuvant therapy; BMI; body mass index; colon cancer; obesity

Indexed keywords

FLUOROURACIL;

ADJUVANT THERAPY; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; EUROPE; FEMALE; FLUOROURACIL; HUMANS; MALE; NEOPLASM STAGING; NORTH AMERICA; OVERWEIGHT; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL ANALYSIS; THINNESS;

EID: 84876027084     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27938     Document Type: Article

References (40)

1. World Health Organization. Report of a WHO Consultation to Obesity. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: World Health Organization; 1998.
2. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM,. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004; 291: 2847-2850.
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL,. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288: 1723-1727.
4. Larsson SC, Wolk A,. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007; 86: 556-565.
5. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006; 98: 920-931.
6. Moghaddam AA, Woodward M, Huxley R,. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2533-2547.
7. Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ,. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol. 2000; 152: 847-854.
8. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003; 348: 1625-1638.
9. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003; 98: 484-495.
10. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol. 2008; 26: 4109-4115.
11. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C,. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010; 16: 1884-1893.
12. Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006; 98: 1647-1654.
13. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM,. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol. 2012; 30: 42-52.
14. O'Connell MJ, Campbell ME, Goldberg RM, et al. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol. 2008; 26: 2336-2341.
15. Cox D,. Regression models and life tables. J R Stat Soc B. 1972; 34: 187-200.
16. Harrell F Jr,. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag; 2001.
17. Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A,. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control. 2006; 17: 63-70.
18. Flegal KM, Graubard BI, Williamson DF, Gail MH,. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007; 298: 2028-2037.
19. Dai Z, Xu YC, Niu L,. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007; 13: 4199-4206.
20. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M,. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371: 569-578.
21. Power ML, Schulkin J,. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr. 2008; 99: 931-940.
22. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U,. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983; 72: 1150-1162.
23. Giovannucci E,. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007; 86: s836-s842.
24. Sandhu MS, Dunger DB, Giovannucci EL,. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002; 94: 972-980.
25. Wolpin BM, Meyerhardt JA, Chan AT, et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009; 27: 176-185.
26. McTiernan A, Wu L, Chen C, et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring). 2006; 14: 1662-1677.
27. Terry PD, Miller AB, Rohan TE,. Obesity and colorectal cancer risk in women. Gut. 2002; 51: 191-194.
28. Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS,. Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol. 2006; 24: 5680-5686.
29. Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB,. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol. 2009; 27: 4542-4547.
30. Delellis Henderson K, Duan L, Sullivan-Halley J, et al. Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol. 2010; 171: 415-425.
31. O'Gorman P, McMillan DC, McArdle CS,. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer. 2000; 37: 36-40.
32. Andreyev HJ, Norman AR, Oates J, Cunningham D,. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998; 34: 503-509.
33. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN,. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012; 99: 550-557.
34. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12: 489-495.
35. Kotler DP,. Cachexia. Ann Intern Med. 2000; 133: 622-634.
36. Morley JE, Thomas DR, Wilson MM,. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83: 735-743.
37. Koster A, Leitzmann MF, Schatzkin A, et al. The combined relations of adiposity and smoking on mortality. Am J Clin Nutr. 2008; 88: 1206-1212.
38. Seidell JC, Verschuren WM, van Leer EM, Kromhout D,. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med. 1996; 156: 958-963.
39. Visscher TL, Seidell JC, Menotti A, et al. Underweight and overweight in relation to mortality among men aged 40-59 and 50-69 years: the Seven Countries Study. Am J Epidemiol. 2000; 151: 660-666.
40. Prizment AE, Flood A, Anderson KE, Folsom AR,. Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2229-2237.